Keyword: FLX Bio


By targeting regulatory T cells and myeloid cells, FLX hopes to enable the immune system to launch full-force strikes against tumors.

FierceBiotech's 2018 Fierce 15

All of our Fierce 15 winners care deeply about biomedical science and understand the unique pressure to translate every penny they've raised into something truly innovative for patients. And it seems this passion is infectious when it comes to luring investors.